The Medicines Company Buys A German Firm | Chemical & Engineering News
Volume 86 Issue 32 | p. 21 | Concentrates
Issue Date: August 11, 2008

The Medicines Company Buys A German Firm

Department: Business

The Medicines Co. has acquired Germany's Curacyte Discovery and its lead compound, CU-2010, a small-molecule serine protease inhibitor that is being developed for the prevention of surgical blood loss. TMC, based in Parsippany, N.J., paid about $22 million and will make an additional payment of about $16 million to Curacyte's owners if CU-2010 makes it to Phase II clinical trials. TMC expects Phase I testing to start later this year.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment